Physicochemical Properties
| Molecular Formula | C57H104O6 |
| Molecular Weight | 885.43 |
| Exact Mass | 884.783 |
| CAS # | 537-39-3 |
| PubChem CID | 5364673 |
| Appearance | White to off-white solid powder |
| Density | 0.921g/cm3 |
| Boiling Point | 818.7ºC at 760mmHg |
| Melting Point | 42ºC |
| Flash Point | 302.6ºC |
| Index of Refraction | 1.4381 (estimate) |
| LogP | 18.097 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 53 |
| Heavy Atom Count | 63 |
| Complexity | 1010 |
| Defined Atom Stereocenter Count | 0 |
| SMILES | CCCCCCCC/C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC/C=C/CCCCCCCC)COC(=O)CCCCCCC/C=C/CCCCCCCC |
| InChi Key | PHYFQTYBJUILEZ-WUOFIQDXSA-N |
| InChi Code | InChI=1S/C57H104O6/c1-4-7-10-13-16-19-22-25-28-31-34-37-40-43-46-49-55(58)61-52-54(63-57(60)51-48-45-42-39-36-33-30-27-24-21-18-15-12-9-6-3)53-62-56(59)50-47-44-41-38-35-32-29-26-23-20-17-14-11-8-5-2/h25-30,54H,4-24,31-53H2,1-3H3/b28-25+,29-26+,30-27+ |
| Chemical Name | 2,3-bis[[(E)-octadec-9-enoyl]oxy]propyl (E)-octadec-9-enoate |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| Additional Infomation |
Trielaidin is a triglyceride formed by esterification of the three hydroxy groups of glycerol with elaidic acid. It is functionally related to an elaidic acid. Trielaidin has been reported in Ganoderma carnosum with data available. (Z)-9-Octadecenoic acid 1,2,3-propanetriyl ester. |
Solubility Data
| Solubility (In Vitro) | Ethanol: 10 mg/mL (11.29 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 1 mg/mL (1.13 mM) (saturation unknown) in 10% EtOH + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 10.0 mg/mL clear EtOH stock solution to 400 μL of PEG300 and mix evenly; then add 50 μL of Tween-80 to the above solution and mix evenly; then add 450 μL of normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: 1 mg/mL (1.13 mM) in 10% EtOH + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), suspension solution; with ultrasonication. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 10.0 mg/mL clear EtOH stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 3: ≥ 1 mg/mL (1.13 mM) (saturation unknown) in 10% EtOH + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 10.0 mg/mL clear EtOH stock solution to 900 μL of corn oil and mix well.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 1.1294 mL | 5.6470 mL | 11.2939 mL | |
| 5 mM | 0.2259 mL | 1.1294 mL | 2.2588 mL | |
| 10 mM | 0.1129 mL | 0.5647 mL | 1.1294 mL |